首頁
瀏覽量: 194
- 產(chǎn)品名稱： Research Grade Tildrakizumab ( 替曲吉珠單抗 )
- 產(chǎn)品貨號： CSD00305
- 貨期： 現(xiàn)貨
- 價格與訂購： 600
- 數(shù)量：
庫存： 100
- 規(guī)格： 100μg 1mg
- 產(chǎn)品信息
- 如何訂購
貨號（Catalog No.）
CSD00305
通用名INN
Tildrakizumab
純度(Purity)
>95%
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內毒素(Endotoxin level)
Please contact with the lab for this information.
產(chǎn)品描述(Description)
Tildrakizumab is a high-affinity, humanized, IgG1 κ antibody targeting interleukin 23 p19 that shows promise in the evolution of treatment strategy in chronic plaque psoriasis 3.The Food and Drug Administration (FDA) approved ILUMYA (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy in March 2018. The approved recommended dosage of ILUMYA is a subcutaneous injection of 100 mg at Weeks 0, 4, and every 12 weeks thereafter 7.
A study was performed on the pharmacokinetics of this drug on various ethnicities. The pharmacokinetics of tildrakizumab were similar in Japanese, Caucasian, and Chinese subjects 5.
別名(Alternative names)
MK-3222, SCH900222
靶點;物種(Specificity target name;species)
IL23A[Homo sapiens]
種類(Species)
Humanized
受體鑒定(Receptor identification)
IgG1-kappa
分子量(MV)
144400.0 Da
CAS
1326244-10-3
存儲條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .
地 址：
產(chǎn)品銷售：
E - mail ：
郵 編：
Amily
